Dr. Paul Hagerman

Dr. Paul Hagerman is a biomedical researcher known for his work on neurodegenerative diseases, particularly Friedreich’s ataxia. He investigates how genetic mutations lead to nervous system damage and explores potential treatments to slow or prevent disease progression. His research aims to understand the molecular mechanisms behind these conditions, contributing to the development of therapies that could improve quality of life for affected individuals. Through his work, Dr. Hagerman advances our understanding of how genetic and cellular factors influence neurological health, offering hope for future medical interventions.